Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study-Reference-Cited by-同舟云学术

Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study

Published:2019-07-25 Issue:9 Volume:46 Page:752-758
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Lee Min‐Geol¹,Huang Yu‐Huei²,Lee Joo‐Heung³,Lee Seung‐Chul⁴,Kim Tae‐Gyun¹^ORCID,Aw Derrick Chen‐Wee⁵,Bao Weibin⁶,Dee Cathleen Michelle A.⁷,Guana Adriana⁶,Tsai Tsen‐Fang⁸^ORCID

Affiliation:

1. Department of Dermatology Severance HospitalYonsei University College of Medicine Seoul Korea

2. Department of Dermatology Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University Taoyuan Taiwan

3. Department of Dermatology Samsung Medical Center Sungkyunkwan University School of Medicine SeoulKorea

4. Department of Dermatology Chonnam National University Medical School Gwangju Korea

5. Division of Medicine Sengkang General Hospital Singapore City Singapore

6. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA

7. Novartis Singapore (Pte) Ltd Singapore City Singapore

8. Department of Dermatology National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15004

Reference40 articles.

1. Guidelines of care for the management of psoriasis and psoriatic arthritis

2. Quality of life and severity of skin changes in the dynamics of psoriasis

3. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis

4. Prevalence and Treatment of Psoriasis in the United Kingdom

5. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis;Dermatology and Therapy;2024-07-29

2. Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2024-06-07

3. Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea;Therapeutic Advances in Chronic Disease;2024-01

4. Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study;Dermatology and Therapy;2022-12-24

5. Lower Limbs are the Most Difficult-to-Treat Body Region of Patients with Psoriasis: Pooled Analysis of CLEAR and CLARITY Studies of Secukinumab Versus Ustekinumab by Body Region;BioDrugs;2022-11